264264-32-6 Usage
Uses
Used in Chemical Synthesis:
3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid is used as a building block in the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and other specialty chemicals. Its unique structure and reactivity make it a valuable intermediate in the development of new molecules with specific properties and applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid is used as a key component in the development of new drugs. Its oxadiazole and benzoic acid moieties can be exploited to design molecules with potential therapeutic effects, such as anti-inflammatory, antimicrobial, or anticancer properties. 3-(5-METHYL-1,2,4-OXADIAZOL-3-YL)BENZOIC ACID's moderate acidity and reactivity with other functional groups can be utilized to optimize the drug's pharmacokinetic and pharmacodynamic properties.
Used in Material Science:
3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid can be used in material science for the development of novel materials with specific properties. Its unique structure and reactivity can be employed to create polymers, coatings, or other materials with tailored characteristics, such as thermal stability, chemical resistance, or specific optical or electronic properties.
Used in Analytical Chemistry:
In analytical chemistry, 3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid can be used as a reagent or a reference compound in various analytical techniques. Its unique chemical properties, such as its moderate acidity and reactivity, can be exploited for the development of new methods for the detection, quantification, or separation of different compounds.
Used in Research and Development:
3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid is used as a research compound in various scientific studies, exploring its potential applications and properties. Researchers can investigate its reactivity, stability, and interactions with other chemicals, as well as its potential use in the development of new materials, drugs, or other products.
Check Digit Verification of cas no
The CAS Registry Mumber 264264-32-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,4,2,6 and 4 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 264264-32:
(8*2)+(7*6)+(6*4)+(5*2)+(4*6)+(3*4)+(2*3)+(1*2)=136
136 % 10 = 6
So 264264-32-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H8N2O3/c1-6-11-9(12-15-6)7-3-2-4-8(5-7)10(13)14/h2-5H,1H3,(H,13,14)
264264-32-6Relevant academic research and scientific papers
Synthesis of benzoic acids containing a 1,2,4-oxadiazole ring
Krasouskaya,Danilova,Baikov,Kolobov,Kofanov
, p. 142 - 145 (2015/10/05)
A new approach to the synthesis of 4and 3-(5-R-1,2,4-oxadiazol-3-yl)benzoic acids via a selective oxidation of 5-R-3-tolyl-1,2,4-oxadiazoles with air oxygen in the presence of a catalytic system based on cobalt acetate was suggested. This synthesis allowed us to obtain the products in higher yields and with shorter sequence of steps as compared to the known procedures.
BENZOTHIAZOLONE DERIVATIVES
-
Page/Page column 19, (2011/11/12)
Compounds of the formula I, in which R1, R2, R3, R3′, R4, R4′, E, E′, E″ and E′″ have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and ca
Pyridazinone derivatives
-
, (2011/11/12)
Compounds of the formula (I) in which D, R1, R2, R3, R4 have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment
2-BENZYLPYRIDAZINONE DERIVATIVES AS MET KINASE INHIBITORS
-
Page/Page column 24, (2010/12/26)
Compounds of the formula I in which R1, R2, R3, R4′ have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
2-OXO-3-BENZYLBENZOXAZOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS MET KINASE INHIBITORS FOR THE TREATMENT OF TUMOURS
-
Page/Page column 40, (2010/12/29)
Compounds of the formula (I), in which R1, R2, R3, R3′, R4, R4′, E, E′, E″ and E′″ have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
-
Page/Page column 26-27, (2010/02/14)
Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
